nodes	percent_of_prediction	percent_of_DWPC	metapath
Buclizine—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.3	0.3	CbGpPWpGaD
Buclizine—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0666	0.0666	CbGpPWpGaD
Buclizine—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0664	0.0664	CbGpPWpGaD
Buclizine—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.056	0.056	CbGpPWpGaD
Buclizine—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0558	0.0558	CbGpPWpGaD
Buclizine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.0407	0.0407	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.023	0.023	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.0229	0.0229	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0206	0.0206	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.0205	0.0205	CbGpPWpGaD
Buclizine—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.0199	0.0199	CbGpPWpGaD
Buclizine—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.0199	0.0199	CbGpPWpGaD
Buclizine—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0166	0.0166	CbGpPWpGaD
Buclizine—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.0166	0.0166	CbGpPWpGaD
Buclizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0149	0.0149	CbGpPWpGaD
Buclizine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.0148	0.0148	CbGpPWpGaD
Buclizine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0128	0.0128	CbGpPWpGaD
Buclizine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0128	0.0128	CbGpPWpGaD
Buclizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.011	0.011	CbGpPWpGaD
Buclizine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.011	0.011	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.0097	0.0097	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.00967	0.00967	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.00881	0.00881	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00878	0.00878	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00838	0.00838	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00835	0.00835	CbGpPWpGaD
Buclizine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.00767	0.00767	CbGpPWpGaD
Buclizine—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.00764	0.00764	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00655	0.00655	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.00653	0.00653	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	0.00612	0.00612	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.0061	0.0061	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	0.00595	0.00595	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.00593	0.00593	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	0.0052	0.0052	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	0.00519	0.00519	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00474	0.00474	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00472	0.00472	CbGpPWpGaD
Buclizine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	0.00433	0.00433	CbGpPWpGaD
Buclizine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	0.00432	0.00432	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	0.0043	0.0043	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00429	0.00429	CbGpPWpGaD
Buclizine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	0.00393	0.00393	CbGpPWpGaD
Buclizine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	0.00392	0.00392	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00351	0.00351	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	0.00351	0.00351	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	0.0035	0.0035	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.0035	0.0035	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	0.00254	0.00254	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	0.00253	0.00253	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—PTH—nephrolithiasis	0.00232	0.00232	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	0.00232	0.00232	CbGpPWpGaD
Buclizine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	0.00117	0.00117	CbGpPWpGaD
Buclizine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	0.00116	0.00116	CbGpPWpGaD
